LASHELLE HENDERSON: Open Payments
NPI 1831302264 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,360 in 195 payments from 14 companies in 2025. Trend: 2023 $178 · 2024 $2,377 · 2025 $3,360
Food & beverage: $3,249Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $494 |
| E.R. Squibb & Sons, L.L.C. | 4 | $479 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $398 |
| Otsuka America Pharmaceutical, Inc. | 13 | $368 |
| Lundbeck LLC | 25 | $362 |
| Janssen Pharmaceuticals, Inc | 29 | $361 |
| Alkermes, Inc. | 21 | $287 |
| ABBVIE INC. | 13 | $218 |
| Neurocrine BioSciences, Inc. | 12 | $160 |
| Vanda Pharmaceuticals Inc. | 10 | $148 |
Products named: COBENFY, CAPLYTA, INVEGA SUSTENNA, REXULTI, ARISTADA, ABILIFY MAINTENA, VRAYLAR, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
